Detection of CD4+ T-lymphocytes from hemodialyzed patients by surface plasmon resonance

A surface plasmon resonance (SPR) method was presented to discriminate hemodialyzed T-lymphocytes from the normal based on antibody--cell recognition. By dynamic reaction with fixed anti-human CD4 antibody, SPR could offer significant signals to distinguish hemodialyzed patients from the healthy con...

Full description

Saved in:
Bibliographic Details
Published inChinese chemical letters Vol. 23; no. 12; pp. 1393 - 1395
Main Authors Wang, Hai Yan, Li, Jian Jun, Cao, Xiao Na, Xu, Ji Ying, Liu, Mei Rong, Chen, Yi
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.12.2012
School of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China%East Section of Dongzhimen Hospital Affiliated, Beijing 101100, China%Community Health Service of Beijing Sport University, Beijing 100190, China%Key Laboratory of Analytical Chemistry for Living Biosystems, ICCAS, Beijing 100190, China
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A surface plasmon resonance (SPR) method was presented to discriminate hemodialyzed T-lymphocytes from the normal based on antibody--cell recognition. By dynamic reaction with fixed anti-human CD4 antibody, SPR could offer significant signals to distinguish hemodialyzed patients from the healthy controls within 200 s after the cell injection in respect of either rising speed or maximum binding capacity (p 〈 0.01). The ratio method is also used to exclude the non-specific adsorption. The percentage of hemodialyzed patients' CD4+ T ceils against the healthy control is 69 ± 18%. The most attractive of the present method is its ability to detect the intact and label-free lymphocytes, and further to detect the subpopulations, or proteins secreted by the desired lymphocytes subset.
Bibliography:Hemodialyzed patients; CD4+ T-lymphocytes; Antibody-antigen interactions; SPR
11-2710/O6
A surface plasmon resonance (SPR) method was presented to discriminate hemodialyzed T-lymphocytes from the normal based on antibody--cell recognition. By dynamic reaction with fixed anti-human CD4 antibody, SPR could offer significant signals to distinguish hemodialyzed patients from the healthy controls within 200 s after the cell injection in respect of either rising speed or maximum binding capacity (p 〈 0.01). The ratio method is also used to exclude the non-specific adsorption. The percentage of hemodialyzed patients' CD4+ T ceils against the healthy control is 69 ± 18%. The most attractive of the present method is its ability to detect the intact and label-free lymphocytes, and further to detect the subpopulations, or proteins secreted by the desired lymphocytes subset.
ISSN:1001-8417
1878-5964
DOI:10.1016/j.cclet.2012.10.017